|
1
|
Holmes D: A disease of growth. Nature.
521:S2–S3. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
NCCN Clinical Practice Guidelines in
Oncology: Colon Cancer (version 3.2014). National Comprehensive
Cancer Network; 2014
|
|
3
|
Muratore A, Zorzi D, Bouzari H, Amisano M,
Massucco P, Sperti E and Capussotti L: Asymptomatic colorectal
cancer with un-resectable liver metastases: Immediate colorectal
resection or up-front systemic chemotherapy? Ann Surg Oncol.
14:766–770. 2007. View Article : Google Scholar
|
|
4
|
Tsai MS, Su YH, Ho MC, Liang JT, Chen TP,
Lai HS and Lee PH: Clinicopathological features and prognosis in
resectable synchronous and metachronous colorectal liver
metastasis. Ann Surg Oncol. 14:786–794. 2007. View Article : Google Scholar
|
|
5
|
Lee ST, Strunk KM and Spritz RA: A survey
of protein tyrosine kinase mRNAs expressed in normal human
melanocytes. Oncogene. 8:3403–3410. 1993.PubMed/NCBI
|
|
6
|
Park SK, Lee HS and Lee ST:
Characterization of the human full-length PTK7 cDNA encoding a
receptor protein tyrosine kinase-like molecule closely related to
chick KLG. J Biochem. 119:235–239. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Katoh M: WNT/PCP signaling pathway and
human cancer (Review). Oncol Rep. 14:1583–1588. 2005.PubMed/NCBI
|
|
8
|
Easty DJ, Mitchell PJ, Patel K, Flørenes
VA, Spritz RA and Bennett DC: Loss of expression of receptor
tyrosine kinase family genes PTK7 and SEK in metastatic melanoma.
Int J Cancer. 71:1061–1065. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Behbahani TE, Thierse C, Baumann C, Holl
D, Bastian PJ, von Ruecker A, Müller SC, Ellinger J and Hauser S:
Tyrosine kinase expression profile in clear cell renal cell
carcinoma. World J Urol. 30:559–565. 2012. View Article : Google Scholar
|
|
10
|
Lin Y, Zhang LH, Wang XH, Xing XF, Cheng
XJ, Dong B, Hu Y, Du H, Li YA, Zhu YB, et al: PTK7 as a novel
marker for favorable gastric cancer patient survival. J Surg Oncol.
106:880–886. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin J, Ryu HS, Lee KB and Jang JJ: High
expression of protein tyrosine kinase 7 significantly associates
with invasiveness and poor prognosis in intrahepatic
cholangiocarcinoma. PLoS One. 9:e902472014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Li G, Yin Y, Wang J, Wang H, Wei
W, Guo Q, Ma H, Shi Q, Zhou X, et al: PTK7 protein is decreased in
epithelial ovarian carcinomas with poor prognosis. Int J Clin Exp
Pathol. 7:7881–7889. 2014.
|
|
13
|
Marullo M, Zuccato C, Mariotti C, Lahiri
N, Tabrizi SJ, Di Donato S and Cattaneo E: Expressed Alu repeats as
a novel, reliable tool for normalization of real-time quantitative
RT-PCR data. Genome Biol. 11:R92010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Guan XY, Dong B, Zhao M, Wu JH,
Tian XY and Hao CY: Expression of MMP-9 and WAVE3 in colorectal
cancer and its relationship to clinicopathological features. J
Cancer Res Clin Oncol. 138:2035–2044. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jung JW, Shin WS, Song J and Lee ST:
Cloning and characterization of the full-length mouse Ptk7 cDNA
encoding a defective receptor protein tyrosine kinase. Gene.
328:75–84. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu X, Borchers AG, Jolicoeur C, Rayburn H,
Baker JC and Tessier-Lavigne M: PTK7/CCK-4 is a novel regulator of
planar cell polarity in vertebrates. Nature. 430:93–98. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shin WS, Maeng YS, Jung JW, Min JK, Kwon
YG and Lee ST: Soluble PTK7 inhibits tube formation, migration, and
invasion of endothelial cells and angiogenesis. Biochem Biophys Res
Commun. 371:793–798. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Caddy J, Wilanowski T, Darido C, Dworkin
S, Ting SB, Zhao Q, Rank G, Auden A, Srivastava S, Papenfuss TA, et
al: Epidermal wound repair is regulated by the planar cell polarity
signaling pathway. Dev Cell. 19:138–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Müller-Tidow C, Schwäble J, Steffen B,
Tidow N, Brandt B, Becker K, Schulze-Bahr E, Halfter H, Vogt U,
Metzger R, et al: High-throughput analysis of genome-wide receptor
tyrosine kinase expression in human cancers identifies potential
novel drug targets. Clin Cancer Res. 10:1241–1249. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gobble RM, Qin LX, Brill ER, Angeles CV,
Ugras S, O'Connor RB, Moraco NH, Decarolis PL, Antonescu C and
Singer S: Expression profiling of liposarcoma yields a multigene
predictor of patient outcome and identifies genes that contribute
to liposarcomagenesis. Cancer Res. 71:2697–2705. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shin WS, Kwon J, Lee HW, Kang MC, Na HW,
Lee ST and Park JH: Oncogenic role of protein tyrosine kinase 7 in
esophageal squamous cell carcinoma. Cancer Sci. 104:1120–1126.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang H, Wang A, Qi S, Cheng S, Yao B and
Xu Y: Protein tyrosine kinase 7 (PTK7) as a predictor of lymph node
metastases and a novel prognostic biomarker in patients with
prostate cancer. Int J Mol Sci. 15:11665–11677. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Q, Zhang C, Yuan J, Fu J, Wu M, Su J,
Wang X, Yuan X and Jiang W: PTK7 regulates Id1 expression in
CD44-high glioma cells. Neuro-oncol. 17:505–515. 2015. View Article : Google Scholar :
|
|
24
|
Kim JH, Kwon J, Lee HW, Kang MC, Yoon HJ,
Lee ST and Park JH: Protein tyrosine kinase 7 plays a tumor
suppressor role by inhibiting ERK and AKT phosphorylation in lung
cancer. Oncol Rep. 31:2708–2712. 2014.PubMed/NCBI
|
|
25
|
Hishida M, Inokawa Y, Takano N, Nishikawa
Y, Iwata N, Kanda M, Tanaka C, Kobayashi D, Yamada S, Nakayama G,
et al: Protein tyrosine kinase 7: A hepatocellular
carcinoma-related gene detected by triple-combination array. J Surg
Res. 195:444–453. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mossie K, Jallal B, Alves F, Sures I,
Plowman GD and Ullrich A: Colon carcinoma kinase-4 defines a new
subclass of the receptor tyrosine kinase family. Oncogene.
11:2179–2184. 1995.PubMed/NCBI
|
|
27
|
Lhoumeau AC, Martinez S, Boher JM, Monges
G, Castellano R, Goubard A, Doremus M, Poizat F, Lelong B, de
Chaisemartin C, et al: Overexpression of the Promigratory and
Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical
Outcome in Colorectal Cancer. PLoS One. 10:e01237682015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Endoh H, Tomida S, Yatabe Y, Konishi H,
Osada H, Tajima K, Kuwano H, Takahashi T and Mitsudomi T:
Prognostic model of pulmonary adenocarcinoma by expression
profiling of eight genes as determined by quantitative real-time
reverse transcriptase polymerase chain reaction. J Clin Oncol.
22:811–819. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jung JW, Ji AR, Lee J, Kim UJ and Lee ST:
Organization of the human PTK7 gene encoding a receptor protein
tyrosine kinase-like molecule and alternative splicing of its mRNA.
Biochim Biophys Acta. 1579:153–163. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Golubkov VS, Chekanov AV, Cieplak P,
Aleshin AE, Chernov AV, Zhu W, Radichev IA, Zhang D, Dong PD and
Strongin AY: The Wnt/planar cell polarity protein-tyrosine kinase-7
(PTK7) is a highly efficient proteolytic target of membrane type-1
matrix metalloproteinase: Implications in cancer and embryogenesis.
J Biol Chem. 285:35740–35749. 2010. View Article : Google Scholar : PubMed/NCBI
|
